Supernus Pharmaceuticals
Presencia
Supernus Pharmaceuticals es una de las ...
Supernus Pharmaceuticals es una empresa que cotiza bajo el símbolo de cotización SUPN (US).
Ejecutivos
Ver el organigrama con sus 17 ejecutivos principales
Biografías más buscadas en Supernus Pharmaceuticals
- Jack Khattar, President, Chief Executive Officer and Director
- Carrolee Barlow, Director
- John Siebert, Director
Recientes movimientos de ejecutivos en Supernus Pharmaceuticals
- Bethany Sensenig, se ha incorporado a la empresa como Director (noticia publicada el 22 de agosto de 2023).
Crear su alerta
para seguir los movimientos de los ejecutivos en Supernus Pharmaceuticals.
Farmacia
Supernus Pharmaceuticals tiene 1.860 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacia
- MedMen has filed for bankruptcy protection (publicado el 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado el 23 de marzo de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado el 19 de marzo de 2024).
Otros contactos sugeridos en el sector Farmacia
Noticias
Últimos comunicados de prensa de Supernus Pharmaceuticals
- Supernus Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022 | Supernus Pharmaceuticals
- Supernus to Participate in the Jefferies Healthcare Conference | Supernus Pharmaceuticals
- Supernus Announces First Quarter 2022 Financial Results | Supernus Pharmaceuticals
- Supernus Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call on May 9, 2022 | Supernus Pharmaceuticals
- Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults | Supernus Pharmaceuticals
- Supernus Pharmaceuticals Appoints James Kelly as Chief Financial Officer - Supernus Pharmaceuticals
- Supernus Submits NDA for SPN-830 for Continuous Treatment of ON-OFF Episodes in Adults with Parkinson’s Disease Who Have Failed Two Treatments - Supernus Pharmaceuticals
- Supernus to Present at the Morgan Stanley 18th Annual Global Healthcare Conference - Supernus Pharmaceuticals
- Supernus to Present at the Wells Fargo Virtual Health Care Conference - Supernus Pharmaceuticals
- Supernus Announces Second Quarter 2020 Financial Results - Supernus Pharmaceuticals
- View more press releases Close
Redes sociales sobre Supernus Pharmaceuticals
- Supernus Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
- Supernus Pharmaceuticals en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Bethany Sensenig 
Llame a Supernus Pharmaceuticals al +1 301...
